Regulatory Control of Radiopharmaceuticals

  • Barbara Y. Croft


The health of the nuclear medicine and radiopharmaceutical industry relies on the ability to continue producing answers to the most pressing medical problems and to produce a continuous supply of the needed materials. Thus there is the need not only for research at the leading edge of medicine but for steady production for a number of years after the initial introduction of a product, especially, so the use of the material may be disseminated from the academic centers to the community hospitals.


Radioactive Material Package Insert Agreement State Executive Branch Nuclear Regulatory Commission 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Barbara Y. Croft
    • 1
  1. 1.Department of RadiologyUniversity of Virginia Health Sciences CenterCharlottesvilleUSA

Personalised recommendations